CAINI, PATRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.780
EU - Europa 2.582
AS - Asia 1.656
SA - Sud America 158
AF - Africa 52
OC - Oceania 38
Totale 9.266
Nazione #
US - Stati Uniti d'America 4.738
RU - Federazione Russa 1.042
SG - Singapore 485
CN - Cina 360
PL - Polonia 347
HK - Hong Kong 308
SE - Svezia 283
IE - Irlanda 255
VN - Vietnam 172
IT - Italia 165
BR - Brasile 125
KR - Corea 125
DE - Germania 115
FI - Finlandia 83
FR - Francia 83
GB - Regno Unito 67
UA - Ucraina 67
JP - Giappone 47
IN - India 42
TR - Turchia 42
AU - Australia 37
CA - Canada 25
CI - Costa d'Avorio 24
NL - Olanda 18
AR - Argentina 13
BE - Belgio 13
JO - Giordania 13
MX - Messico 13
BD - Bangladesh 12
IQ - Iraq 10
CH - Svizzera 8
EC - Ecuador 8
ZA - Sudafrica 7
CZ - Repubblica Ceca 6
PK - Pakistan 6
EG - Egitto 5
ID - Indonesia 5
NG - Nigeria 5
RO - Romania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
MA - Marocco 4
DK - Danimarca 3
ES - Italia 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BY - Bielorussia 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
KG - Kirghizistan 2
MT - Malta 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TW - Taiwan 1
VE - Venezuela 1
Totale 9.266
Città #
Santa Clara 1.110
Ashburn 445
Fairfield 394
Warsaw 347
Singapore 345
Chandler 280
Dublin 255
Hong Kong 251
San Jose 247
Woodbridge 201
Seattle 178
Wilmington 165
Cambridge 156
Beijing 150
Houston 130
Seoul 125
Ann Arbor 115
Jacksonville 103
Buffalo 79
The Dalles 75
Princeton 61
Los Angeles 59
Ho Chi Minh City 54
Lauterbourg 52
Altamura 50
Boston 48
Tokyo 47
Lawrence 45
Boardman 44
Hanoi 39
Dallas 37
Izmir 35
Melbourne 35
Bremen 34
Munich 31
Medford 29
Florence 27
Mumbai 27
New York 27
Abidjan 24
Shanghai 21
Hefei 20
San Diego 20
Paris 19
Turku 18
Moscow 15
Washington 15
Brussels 13
Falls Church 13
Norwalk 13
London 10
São Paulo 10
Toronto 10
Bern 8
Frankfurt am Main 8
Helsinki 8
Kent 8
Redondo Beach 8
Brooklyn 7
Da Nang 7
Atlanta 6
Brasília 6
Chicago 6
Council Bluffs 6
Hillsboro 6
Orem 6
Rome 6
Salerno 6
Stockholm 6
West Jordan 6
Abuja 5
Auburn Hills 5
Baghdad 5
Clifton 5
Frankfurt Am Main 5
Rio de Janeiro 5
Tashkent 5
Andover 4
Barnet 4
Brno 4
Cluj-Napoca 4
Denver 4
Jakarta 4
Manchester 4
Mexico City 4
Montreal 4
Amsterdam 3
Biên Hòa 3
Caserta 3
Dhaka 3
Guangzhou 3
Hải Dương 3
Johannesburg 3
Karachi 3
Milan 3
Ninh Bình 3
Old Bridge 3
Phoenix 3
Phủ Từ Sơn 3
Poplar 3
Totale 6.380
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 315
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 255
The effects of phosphate on the contraction of single skeletal myofibrils 231
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 219
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 219
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 207
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 197
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 195
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 194
Host genetic determinants in HCV-related mixed cryoglobulinemia 190
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 184
Analysis of HCV persistence in patients with sustained virological response 184
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 177
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 174
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 172
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 170
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 169
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 169
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 168
Involvement of PI3K in HCV-related lymphoproliferative disorders 167
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 165
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 164
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 164
T(14;18) translocation in chronic hepatitis C virus infection 162
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 161
Host genetic determinants in HCV-related mixed cryoglobulinemia 161
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 157
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 155
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 155
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 154
Crioglobulinemia e linfoma in corso di infezione da HCV 150
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 147
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 145
Hepatitis C virus core protein enhances B lymphocyte proliferation 144
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 139
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 138
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 138
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 138
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 135
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 133
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 132
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 130
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 127
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 122
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 118
Eventi Oncomolecolari nella Crioglobulinemia Mista 115
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 114
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 111
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 111
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 108
Reply: HCV infection and psychopathological disorders 96
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 94
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 91
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 91
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 89
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 88
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 85
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 85
La cimentazione della proteina CD81 con ligandi specifici promuove la proliferazione di cellule B e l’espressione della proteina c-myc 83
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 82
null 48
Totale 9.279
Categoria #
all - tutte 24.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 45 32
2021/2022431 4 49 15 15 15 17 16 30 21 9 90 150
2022/20231.154 100 152 75 108 114 226 152 59 124 8 21 15
2023/2024363 17 52 68 28 23 66 7 65 8 8 10 11
2024/20252.856 93 286 178 434 966 368 43 171 99 58 90 70
2025/20262.245 353 345 154 114 251 103 314 104 291 178 38 0
Totale 9.279